Loading...
Early-Stage Diversification And High Capex Will Test Earnings Before Longer-Term Benefits Emerge
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
10 Jan 26
Views
13
10 Jan
₹221.95
AnalystLowTarget's Fair Value
₹320.00
30.6% undervalued intrinsic discount1Y
-36.2%7D
-0.3%1Y
-36.2%7D
-0.3%You can edit this narrative until Jan 11 12:10 PM. Then, changes will post as Updates.
Author's Valuation
₹32030.6% undervalued intrinsic discount
AnalystLowTarget Fair Value